Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melphalan With or Without Tumor Necrosis Factor in Unresectable High Grade Soft Tissue Sarcomas of the Extremity
NCT00019968Phase 2Completed
- Sponsor
- National Institutes of Health
- Start
- Aug 1999
- Modality
- Gene Editing, Gene Silencing, Cytokines & Interferons
01
Overview
A Phase 2 trial of tumor necrosis factor-α in soft tissue sarcoma (STS), sponsored by National Institutes of Health. Started Aug 1999; status: completed.
02
Drugs
tumor necrosis factor-α
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT00019968.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00019968.